Molecular Diagnostics In Cancer Testing Market Report

Europe Molecular Diagnostics In Cancer Testing Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 11, 2019
  • PAGES：176
  • REPORT CODE：GMM313087
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Molecular Diagnostics In Cancer Testing market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Molecular Diagnostics In Cancer Testing Market Segmentations:

    By Player:

    • Ambry Genetics

    • Biodesix

    • BioMerieux

    • Cancer Genetics

    • Genmark Diagnostics

    • Flatiron Health

    • Clarient, Inc. (GE Healthcare)

    • Counsyl

    • Genomic Health

    • Clarient, Inc (GE Healthcare)

    • HTG Molecular Diagnostics

    • Epigenomics

    • Myriad Genetics

    • Nanostring

    • NSTG

    • LabCorp

    • Nuvera Biosciences

    • Exiqon

    • Abbott Molecular Diagnostics

    • Genomictree

    • Orion Genomics

    • Agendia

    • Invitae

    • Genoptix (Novartis)

    • Neogenomics

    • BioTheranostics (AviaraDx)

    • Accugenomics

    • Exact Sciences Corporation

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Molecular Diagnostics In Cancer Testing Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Molecular Diagnostics In Cancer Testing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Molecular Diagnostics In Cancer Testing by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Molecular Diagnostics In Cancer Testing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Molecular Diagnostics In Cancer Testing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Molecular Diagnostics In Cancer Testing for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Molecular Diagnostics In Cancer Testing for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Molecular Diagnostics In Cancer Testing for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Molecular Diagnostics In Cancer Testing Production Analysis by Top Regions

    • 5.2 Europe Molecular Diagnostics In Cancer Testing Consumption Analysis by Top Regions

    • 5.3 Europe Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.3 France Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    6 Product Circulation of Molecular Diagnostics In Cancer Testing Market among Top Countries

    • 6.1 Top 5 Export Countries in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 7.1 Germany Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 7.2 Germany Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    8. UK Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 8.1 UK Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 8.2 UK Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    9. France Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 9.1 France Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 9.2 France Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    10. Italy Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 10.1 Italy Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 10.2 Italy Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    11. Spain Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 11.1 Spain Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 11.2 Spain Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    12. Poland Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 12.1 Poland Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 12.2 Poland Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    13. Russia Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 13.1 Russia Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 13.2 Russia Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    14. Switzerland Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 14.1 Switzerland Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 14.2 Switzerland Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    15. Turkey Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 15.1 Turkey Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 15.2 Turkey Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Landscape Analysis by Top Countries

      • 16.3.1 Denmark Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

      • 16.3.2 Finland Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

      • 16.3.3 Norway Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

      • 16.3.4 Sweden Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

      • 16.3.6 Iceland Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Landscape Analysis by Top Countries

      • 17.3.1 Belgium Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

      • 17.3.2 Netherlands Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

      • 17.3.3 Luxembourg Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Landscape Analysis by Top Countries

      • 18.3.1 Estonia Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

      • 18.3.2 Latvia Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

      • 18.3.3 Lithuania Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Ambry Genetics

      • 19.1.1 Ambry Genetics Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Biodesix

      • 19.2.1 Biodesix Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 BioMerieux

      • 19.3.1 BioMerieux Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Cancer Genetics

      • 19.4.1 Cancer Genetics Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Genmark Diagnostics

      • 19.5.1 Genmark Diagnostics Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Flatiron Health

      • 19.6.1 Flatiron Health Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Clarient, Inc. (GE Healthcare)

      • 19.7.1 Clarient, Inc. (GE Healthcare) Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Counsyl

      • 19.8.1 Counsyl Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Genomic Health

      • 19.9.1 Genomic Health Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Clarient, Inc (GE Healthcare)

      • 19.10.1 Clarient, Inc (GE Healthcare) Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 HTG Molecular Diagnostics

      • 19.11.1 HTG Molecular Diagnostics Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Epigenomics

      • 19.12.1 Epigenomics Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Myriad Genetics

      • 19.13.1 Myriad Genetics Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Nanostring

      • 19.14.1 Nanostring Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 NSTG

      • 19.15.1 NSTG Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 LabCorp

      • 19.16.1 LabCorp Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Nuvera Biosciences

      • 19.17.1 Nuvera Biosciences Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Exiqon

      • 19.18.1 Exiqon Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Abbott Molecular Diagnostics

      • 19.19.1 Abbott Molecular Diagnostics Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Genomictree

      • 19.20.1 Genomictree Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Orion Genomics

      • 19.21.1 Orion Genomics Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Agendia

      • 19.22.1 Agendia Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Invitae

      • 19.23.1 Invitae Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Genoptix (Novartis)

      • 19.24.1 Genoptix (Novartis) Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 Neogenomics

      • 19.25.1 Neogenomics Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    • 19.26 BioTheranostics (AviaraDx)

      • 19.26.1 BioTheranostics (AviaraDx) Company Profile and Development Status

      • 19.26.2 Market Performance

      • 19.26.3 Product and Service Introduction

    • 19.27 Accugenomics

      • 19.27.1 Accugenomics Company Profile and Development Status

      • 19.27.2 Market Performance

      • 19.27.3 Product and Service Introduction

    • 19.28 Exact Sciences Corporation

      • 19.28.1 Exact Sciences Corporation Company Profile and Development Status

      • 19.28.2 Market Performance

      • 19.28.3 Product and Service Introduction

    The List of Tables and Figures (Totals 105 Figures and 137 Tables)

    • Figure Product Picture

    • Figure Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure UK Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure France Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Molecular Diagnostics In Cancer Testing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Molecular Diagnostics In Cancer Testing

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Molecular Diagnostics In Cancer Testing by Different Types from 2014 to 2026

    • Table Consumption Share of Molecular Diagnostics In Cancer Testing by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Molecular Diagnostics In Cancer Testing by Different End-Users from 2014 to 2026

    • Table Consumption Share of Molecular Diagnostics In Cancer Testing by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Molecular Diagnostics In Cancer Testing Production by Major Regions

    • Table Europe Molecular Diagnostics In Cancer Testing Production Share by Major Regions

    • Figure Europe Molecular Diagnostics In Cancer Testing Production Share by Major Countries and Regions in 2014

    • Table Europe Molecular Diagnostics In Cancer Testing Consumption by Major Regions

    • Table Europe Molecular Diagnostics In Cancer Testing Consumption Share by Major Regions

    • Table Germany Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table UK Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table France Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Italy Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Spain Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Poland Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Russia Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Switzerland Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Turkey Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Molecular Diagnostics In Cancer Testing Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Germany Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Germany Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Germany Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table UK Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table UK Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table UK Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table UK Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table France Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table France Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table France Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table France Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Italy Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Italy Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Italy Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Italy Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Spain Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Spain Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Spain Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Spain Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Poland Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Poland Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Poland Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Poland Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Russia Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Russia Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Russia Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Russia Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Switzerland Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Switzerland Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Switzerland Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Turkey Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Turkey Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Turkey Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Molecular Diagnostics In Cancer Testing Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Molecular Diagnostics In Cancer Testing Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Molecular Diagnostics In Cancer Testing Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Molecular Diagnostics In Cancer Testing Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Ambry Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ambry Genetics

    • Figure Sales and Growth Rate Analysis of Ambry Genetics

    • Figure Revenue and Market Share Analysis of Ambry Genetics

    • Table Product and Service Introduction of Ambry Genetics

    • Table Company Profile and Development Status of Biodesix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biodesix

    • Figure Sales and Growth Rate Analysis of Biodesix

    • Figure Revenue and Market Share Analysis of Biodesix

    • Table Product and Service Introduction of Biodesix

    • Table Company Profile and Development Status of BioMerieux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux

    • Figure Sales and Growth Rate Analysis of BioMerieux

    • Figure Revenue and Market Share Analysis of BioMerieux

    • Table Product and Service Introduction of BioMerieux

    • Table Company Profile and Development Status of Cancer Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cancer Genetics

    • Figure Sales and Growth Rate Analysis of Cancer Genetics

    • Figure Revenue and Market Share Analysis of Cancer Genetics

    • Table Product and Service Introduction of Cancer Genetics

    • Table Company Profile and Development Status of Genmark Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genmark Diagnostics

    • Figure Sales and Growth Rate Analysis of Genmark Diagnostics

    • Figure Revenue and Market Share Analysis of Genmark Diagnostics

    • Table Product and Service Introduction of Genmark Diagnostics

    • Table Company Profile and Development Status of Flatiron Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Flatiron Health

    • Figure Sales and Growth Rate Analysis of Flatiron Health

    • Figure Revenue and Market Share Analysis of Flatiron Health

    • Table Product and Service Introduction of Flatiron Health

    • Table Company Profile and Development Status of Clarient, Inc. (GE Healthcare)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Clarient, Inc. (GE Healthcare)

    • Figure Sales and Growth Rate Analysis of Clarient, Inc. (GE Healthcare)

    • Figure Revenue and Market Share Analysis of Clarient, Inc. (GE Healthcare)

    • Table Product and Service Introduction of Clarient, Inc. (GE Healthcare)

    • Table Company Profile and Development Status of Counsyl

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Counsyl

    • Figure Sales and Growth Rate Analysis of Counsyl

    • Figure Revenue and Market Share Analysis of Counsyl

    • Table Product and Service Introduction of Counsyl

    • Table Company Profile and Development Status of Genomic Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health

    • Figure Sales and Growth Rate Analysis of Genomic Health

    • Figure Revenue and Market Share Analysis of Genomic Health

    • Table Product and Service Introduction of Genomic Health

    • Table Company Profile and Development Status of Clarient, Inc (GE Healthcare)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Clarient, Inc (GE Healthcare)

    • Figure Sales and Growth Rate Analysis of Clarient, Inc (GE Healthcare)

    • Figure Revenue and Market Share Analysis of Clarient, Inc (GE Healthcare)

    • Table Product and Service Introduction of Clarient, Inc (GE Healthcare)

    • Table Company Profile and Development Status of HTG Molecular Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HTG Molecular Diagnostics

    • Figure Sales and Growth Rate Analysis of HTG Molecular Diagnostics

    • Figure Revenue and Market Share Analysis of HTG Molecular Diagnostics

    • Table Product and Service Introduction of HTG Molecular Diagnostics

    • Table Company Profile and Development Status of Epigenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epigenomics

    • Figure Sales and Growth Rate Analysis of Epigenomics

    • Figure Revenue and Market Share Analysis of Epigenomics

    • Table Product and Service Introduction of Epigenomics

    • Table Company Profile and Development Status of Myriad Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics

    • Figure Sales and Growth Rate Analysis of Myriad Genetics

    • Figure Revenue and Market Share Analysis of Myriad Genetics

    • Table Product and Service Introduction of Myriad Genetics

    • Table Company Profile and Development Status of Nanostring

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nanostring

    • Figure Sales and Growth Rate Analysis of Nanostring

    • Figure Revenue and Market Share Analysis of Nanostring

    • Table Product and Service Introduction of Nanostring

    • Table Company Profile and Development Status of NSTG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NSTG

    • Figure Sales and Growth Rate Analysis of NSTG

    • Figure Revenue and Market Share Analysis of NSTG

    • Table Product and Service Introduction of NSTG

    • Table Company Profile and Development Status of LabCorp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LabCorp

    • Figure Sales and Growth Rate Analysis of LabCorp

    • Figure Revenue and Market Share Analysis of LabCorp

    • Table Product and Service Introduction of LabCorp

    • Table Company Profile and Development Status of Nuvera Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nuvera Biosciences

    • Figure Sales and Growth Rate Analysis of Nuvera Biosciences

    • Figure Revenue and Market Share Analysis of Nuvera Biosciences

    • Table Product and Service Introduction of Nuvera Biosciences

    • Table Company Profile and Development Status of Exiqon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exiqon

    • Figure Sales and Growth Rate Analysis of Exiqon

    • Figure Revenue and Market Share Analysis of Exiqon

    • Table Product and Service Introduction of Exiqon

    • Table Company Profile and Development Status of Abbott Molecular Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Molecular Diagnostics

    • Figure Sales and Growth Rate Analysis of Abbott Molecular Diagnostics

    • Figure Revenue and Market Share Analysis of Abbott Molecular Diagnostics

    • Table Product and Service Introduction of Abbott Molecular Diagnostics

    • Table Company Profile and Development Status of Genomictree

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomictree

    • Figure Sales and Growth Rate Analysis of Genomictree

    • Figure Revenue and Market Share Analysis of Genomictree

    • Table Product and Service Introduction of Genomictree

    • Table Company Profile and Development Status of Orion Genomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orion Genomics

    • Figure Sales and Growth Rate Analysis of Orion Genomics

    • Figure Revenue and Market Share Analysis of Orion Genomics

    • Table Product and Service Introduction of Orion Genomics

    • Table Company Profile and Development Status of Agendia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agendia

    • Figure Sales and Growth Rate Analysis of Agendia

    • Figure Revenue and Market Share Analysis of Agendia

    • Table Product and Service Introduction of Agendia

    • Table Company Profile and Development Status of Invitae

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Invitae

    • Figure Sales and Growth Rate Analysis of Invitae

    • Figure Revenue and Market Share Analysis of Invitae

    • Table Product and Service Introduction of Invitae

    • Table Company Profile and Development Status of Genoptix (Novartis)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genoptix (Novartis)

    • Figure Sales and Growth Rate Analysis of Genoptix (Novartis)

    • Figure Revenue and Market Share Analysis of Genoptix (Novartis)

    • Table Product and Service Introduction of Genoptix (Novartis)

    • Table Company Profile and Development Status of Neogenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neogenomics

    • Figure Sales and Growth Rate Analysis of Neogenomics

    • Figure Revenue and Market Share Analysis of Neogenomics

    • Table Product and Service Introduction of Neogenomics

    • Table Company Profile and Development Status of BioTheranostics (AviaraDx)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioTheranostics (AviaraDx)

    • Figure Sales and Growth Rate Analysis of BioTheranostics (AviaraDx)

    • Figure Revenue and Market Share Analysis of BioTheranostics (AviaraDx)

    • Table Product and Service Introduction of BioTheranostics (AviaraDx)

    • Table Company Profile and Development Status of Accugenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Accugenomics

    • Figure Sales and Growth Rate Analysis of Accugenomics

    • Figure Revenue and Market Share Analysis of Accugenomics

    • Table Product and Service Introduction of Accugenomics

    • Table Company Profile and Development Status of Exact Sciences Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exact Sciences Corporation

    • Figure Sales and Growth Rate Analysis of Exact Sciences Corporation

    • Figure Revenue and Market Share Analysis of Exact Sciences Corporation

    • Table Product and Service Introduction of Exact Sciences Corporation

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US